Tracker Certificate

    Vontobel Gene Therapy Performance Index

    Open End | Währung: EUR

    EUR
    Bid volume --,---

    EUR
    Ask volume --,---

    Spread

    Vontobel Gene Therapy Performance Index: 123.3784 USD|Last Update:

    Product Overview

    Underlying
    Key figures
    Ratio
    1.1663
    Return (since Inception)
    20.69%
    Volatility p.a.
    27.82%
    Maximum Drawdown
    -31.10%
    Number of Positions
    16
    Sharpe Ratio
    0.11

    Index Overview

    Index Allocation

    Share
    100.00%

    Index Composition: All Constituents

    InstrumentCountriesSectorsCurrenciesWeight

    Krystal Biotech Inc.

    ISIN US5011471027

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 9.38%

    Sarepta Therapeutics Inc.

    ISIN US8036071004

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 8.47%

    Lonza Group AG

    ISIN CH0013841017

    Countries: SwitzerlandSectors: Health Care Currencies: CHFWeight: 8.30%

    Rocket Pharmaceuticals Inc.

    ISIN US77313F1066

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 7.24%

    CRISPR Therapeutics AG

    ISIN CH0334081137

    Countries: SwitzerlandSectors: Health Care Currencies: USDWeight: 7.15%

    Novo Nordisk A/S

    ISIN DK0062498333

    Countries: DenmarkSectors: Health Care Currencies: DKKWeight: 6.76%

    Daiichi Sankyo Co. Ltd.

    ISIN JP3475350009

    Countries: JapanSectors: Health Care Currencies: JPYWeight: 6.43%

    Samsung Biologics Co. Ltd.

    ISIN KR7207940008

    Countries: Republic Of KoreaSectors: Health Care Currencies: KRWWeight: 5.94%

    Amicus Therapeutics Inc.

    ISIN US03152W1099

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 5.93%

    BridgeBio Pharma Inc.

    ISIN US10806X1028

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 5.90%

    Vertex Pharmaceuticals Inc.

    ISIN US92532F1003

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 5.73%

    AstraZeneca Group PLC

    ISIN GB0009895292

    Countries: United KingdomSectors: Health Care Currencies: GBPWeight: 5.66%

    United Therapeutics Corp.

    ISIN US91307C1027

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 5.58%

    Alnylam Pharmaceuticals Inc.

    ISIN US02043Q1076

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 4.89%

    Legend Biotech Corporation

    ISIN US52490G1022

    Countries: United StatesSectors: Health Care Currencies: USDWeight: 4.55%

    WuXi AppTec Co. Ltd.

    ISIN CNE100003F19

    Countries: ChinaSectors: Health Care Currencies: HKDWeight: 2.08%
    Subtotal Share:
    100.00%
    Total :
    100.00%

    Life Cycle

    Initial FixingFirst trading dayOpen-End

    Product Information

    Key Information Document
    Termsheet
    Base Prospectus
    Factsheet
    Index Guide

    About this product

    Tracker certificates enable investors to invest in themes, strategies, regions, or countries, making it easier to diversify even with small amounts of money. Tracker certificates replicate the performance of the underlying asset without leverage, a cap, or capital protection. Investors participate nearly 1:1 in rising and falling prices of the underlying asset. The underlying assets can especially be indices or equity baskets. In this way, you can invest in a whole stock market or basket in only one transaction without having to buy all the individual stocks. This is why tracker certificates are a great product for targeted investment in specific themes.

    Learn more about Tracker Certificates

    Stay updated

    Subscribe to receive information about structured products

    Your personal data will be processed to provide information as per Vontobel Privacy Policy.

    newletter overlay image

    Stay updated

    Subscribe to receive information about structured products

    Your personal data will be processed to provide information as per Vontobel Privacy Policy.

    Vontobel Markets – Bank Vontobel AG and/or affiliates. All rights reserved.

    Please read this information before continuing, as products and services contained on this website are not accessible to certain persons. The information and/or documents offered on this website represent marketing material pursuant to Art. 68 of the Swiss FinSA and are provided for information purposes only. On request, further documents such as the key information document or the prospectus/issue documentation are available free of charge whenever you wish.